Key result
Aspirin for the primary prevention of coronary heart disease and stroke in at-risk patients remains debated, with expert perspectives both supporting and discouraging its daily use.
Why the study?
Should persons at risk for cardiovascular disease take aspirin for primary prevention of coronary heart disease and stroke?
Population
Persons at risk for cardiovascular disease
Design
Editorial
Authors
Loading...
This interactive feature presents arguments for and against the use of aspirin for primary prevention of cardiovascular disease.
Should persons at risk for cardiovascular disease take aspirin for primary prevention of coronary heart disease and stroke?
This interactive feature presents arguments for and against the use of aspirin for primary prevention of cardiovascular disease.
Fernandes et al. (2019) studied this question. Aspirin for the primary prevention of coronary heart disease and stroke in at-risk patients remains debated, with expert perspectives both supporting and discouraging its daily use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: